Silicom Ltd., a leading provider of high-performance networking solutions, will announce its third quarter 2026 financial results on October 29, before the market opens. The company will hold a conference call at 9:00am ET the same day to discuss the results and answer investor questions. Investors can join via webcast or phone, with a replay available for three months. This update is important as it provides insights into Silicom's ongoing performance and strategic direction in the networking technology sector.
Silicom Ltd.'s upcoming third quarter 2026 results announcement is set for October 29. For readers following technology stocks, here is Pluang's market snapshot as of Oct 01, 2026 18:51 WIB: out of 150 priced Technology-sector US stocks tradable on Pluang, 125 rose and 21 fell today. Notable movers include ACN (Accenture plc) with a price of USD 212.50 and a 1-day change of +15.89%, WIT (Wipro Limited) at USD 1.79 with +8.79%, and INFY (Infosys Limited) at USD 11.65 with +8.27%.
Since Satya Nadella became CEO in 2014, Microsoft stock has increased roughly 14 times, delivering an annual growth rate of 23%. This remarkable turnaround ended 14 years of negative growth for the company. However, with Microsoft now investing heavi...
Arthur J. Gallagher & Co., a global insurance brokerage firm, has acquired Albany Insurance Services Limited, a retail insurance broker in New Zealand serving Auckland and Canterbury regions. The acquisition aims to strengthen Gallagher's presence an...
Coinbase shares have fallen nearly 40% from their peak as CEO Brian Armstrong transforms the company into an "everything exchange," reducing reliance on Bitcoin-related revenue from over 50% to 12%. Despite recent earnings misses and a cautious Wall ...
Backpack Exchange's native BP token surged from under $0.50 in mid-September to a new high of $1.65 on October 1, 2026, following the US SEC's Innovation Exemption. This exemption permits limited on-chain trading of tokenized US stocks for up to five...
A study published in The Journal of Molecular Diagnostics validates the Haystack MRD test's high accuracy in detecting residual and recurrent cancer, especially colorectal cancer, with 100% specificity and up to 100% sensitivity at 3 years. The test ...
